SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001818382-24-000026
Filing Date
2024-03-04
Accepted
2024-03-04 06:53:54
Documents
22
Period of Report
2024-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K huma-20240229.htm   iXBRL 8-K 37373
2 EX-1.1 huma02292024exhibit11.htm EX-1.1 317662
3 EX-5.1 huma02292024exhibit51.htm EX-5.1 12018
4 EX-99.1 huma-20240229xexx991.htm EX-99.1 13426
5 EX-99.2 huma-20240229xexx992.htm EX-99.2 15278
10 image_0.jpg GRAPHIC 21724
11 image_02.jpg GRAPHIC 21724
12 letterheada.jpg GRAPHIC 14892
  Complete submission text file 0001818382-24-000026.txt   724883

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20240229.xsd EX-101.SCH 2301
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20240229_def.xml EX-101.DEF 15875
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20240229_lab.xml EX-101.LAB 30803
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20240229_pre.xml EX-101.PRE 16602
23 EXTRACTED XBRL INSTANCE DOCUMENT huma-20240229_htm.xml XML 4275
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 24712807
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)